Michael J Higgins's Net Worth
$6.18 Million
Who is Michael J Higgins?
Michael J Higgins has an estimated net worth of $6.18 Million. This is based on reported shares across multiple companies, which include Voyager Therapeutics, Inc., Pulmatrix, Inc., IRONWOOD PHARMACEUTICALS INC, GENOCEA BIOSCIENCES, INC., and Cyclerion Therapeutics, Inc..
SEC CIK
Michael J Higgins's CIK is 0001478521
Past Insider Trading and Trends
2013 was Michael J Higgins's most active year for acquiring shares with 6 total transactions. Michael J Higgins's most active month to acquire stocks was the month of May. 2013 was Michael J Higgins's most active year for disposing of shares, totalling 7 transactions. Michael J Higgins's most active month to dispose stocks was the month of May. 2014 saw Michael J Higgins paying a total of $203,001.78 for 200,987 shares, this is the most they've acquired in one year. In 2013 Michael J Higgins cashed out on 558,334 shares for a total of $2,540,090.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Voyager Therapeutics, Inc. (VYGR) Snapshot price: $6.13
Interim President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -30.73% | -13.89K |
$6.70 | -$93,069.70 | 31.31K |
Scheduled
|
Jul 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 45.2K |
—
|
—
| 45.2K |
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pulmatrix, Inc. (PULM) Snapshot price: $2.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IRONWOOD PHARMACEUTICALS INC (IRWD) Snapshot price: $4.51
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.70% | 29.1K |
$1.56 | $45,399.12 | 329.1K |
Dec 23
| |||
Form 4
|
—
|
0
|
$8.48 | -$176,976.09 | 300K |
Dec 16
| |||
Form 4
|
—
|
0
|
$7.66 | -$864,246.62 | 300K |
Nov 24
| |||
Form 4
| -100.00% | -50.00K |
$14.56 | -$728,000.00 |
0
|
May 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +44.83% | 108.33K |
$6.17 | -$1,606,589.60 | 350K |
Scheduled
|
Jun 14 - Jun 17
| ||
Form 4
| +26.09% | 50K |
$8.09 | -$718,500.00 | 241.67K |
Mar 5 - Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +53.33% | 66.67K |
$0.60 | $39,999.60 | 191.67K |
Sep 2
| |||
Form 4
| -16.67% | -25.00K |
$15.94 | -$398,500.00 | 125K |
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GENOCEA BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cyclerion Therapeutics, Inc. (CYCN) Snapshot price: $3.18
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |